معرفی
Giorgio Ciminata is a Researcher in the Health Economics & Health Technology Assessment (HEHTA) research group at the University of Glasgow. He holds a PhD in Health Economics (2019), MSc in Health Economic and Decision Modelling (University of Sheffield), and BSc in Cellular and Molecular Biosciences (Sheffield Hallam University). His work focuses on decision analytic modelling, global health, pharmacoepidemiology, and comparative effectiveness research, with expertise in cardiovascular and infectious disease areas.
Giorgio has contributed to studies on healthcare cost analysis for atrial fibrillation management, long-term care outcomes, and policy modeling for cardiometabolic diseases. He also reviews new medical applications for the Scottish Medicines Consortium (SMC). His teaching includes data science components of the MSc in Health Technology Assessment and decision modeling CPD courses.
Key research trends include:
- Clinical economics of anticoagulant therapies
- Health disparities in prescribing practices
- Data integration for care-home pathway analysis
- Global HTA implementation strategies
No formal academic awards are listed, though his extensive publication record reflects research excellence. He supervises BSc/MSc students and collaborates with multidisciplinary teams on healthcare cost-effectiveness and policy projects.
